What You Should Know:
- Launched at CES 2026, Abbott’s Libre Assist,is a generative AI feature within the Libre app that predicts glucose impact before consumption.
- Using a color-coded rating (Green/Yellow/Orange), it acts as a "digital twin" for nutrition. The system then "closes the loop" by reconciling its prediction against real-world data from the Libre 3 Plus sensor, providing a medically validated feedback loop.
The Technical Architecture
Libre Assist can be
Read More
The $149 Disruptor: GoodRx WeightWatchers, LifeMD Aggressively Scale Access to FDA-Approved Wegovy Pill
What You Should Know:
- The healthcare landscape is witnessing a seismic shift in obesity care as GoodRx, WeightWatchers LifeMD launch the newly FDA-approved Wegovy pill (oral semaglutide) with a transparent cash-pay price of $149 per month.
- By combining 16.6% mean weight loss efficacy with a vast retail and telehealth infrastructure, this rollout effectively removes the twin barriers of injection hesitancy and opaque "middleman" pricing.
Breaking the Injection Barrier: The
Read More
b.well Launches First Health AI SDK to Power Actionable Healthcare Assistants
What You Should Know:
- b.well Connected Health has released the first Software Development Kit (SDK) specifically designed to power healthcare AI agents with clean, real-time data from over 2.2 million providers and 300+ health plans.
- The SDK features a proprietary "13-step Data Refinery" that standardizes fragmented records, reducing the token usage for Large Language Models (LLMs) by up to 10x. This infrastructure allows organizations to build AI assistants that can safely take
Read More
Teal Health Partners with Thatch to Offer At-Home Cervical Cancer Screening Benefits
What You Should Know
- Teal Health, the creator of the first FDA-authorized self-collection device for cervical cancer screening, has launched its services on the Thatch Marketplace. This partnership allows employees to use tax-free healthcare dollars (via ICHRA) to purchase at-home screening kits, bypassing the traditional clinic visit.
- The move targets the "working age" gap in cancer prevention, where 1 in 3 U.S. women are currently overdue for screening due to time constraints or
Read More
Vitalis Ventures Invests $15M in Drive Health to Scale Google-Powered AI Agent ‘Avery’
What You Should Know:
- Vitalis Ventures, an investment platform focused on AI-enabled care delivery has invested $15M in Drive Health to scale "Avery," a Google-powered agentic AI platform designed to automate clinical workflows rather than just generate text.
- Unlike standard chatbots, Avery operates as a "clinical workflow engine," handling defined tasks like discharge coordination and symptom monitoring under strict human oversight.
- The funding brings Drive Health’s
Read More
Weight Watchers Launches New GLP-1 Program and AI App Features
What You Should Know:
- Weight Watchers has unveiled a massive platform overhaul integrating GLP-1 prescription management with a redesigned app featuring an AI body scanner and a "Weight Health Score."
- The new "Med+" and "GLP-1 Success" programs offer specialized support for medication users, including nutrition plans to preserve muscle mass and direct access to board-certified physicians. The platform rollout begins globally on December 26, 2025, alongside a major brand
Read More
How Horizon Health and Qure.ai Are Using AI to Catch “Incidental” Lung Cancer
What You Should Know:
- Horizon Health Network, operating across New Brunswick, Canada, has partnered with global health tech leader Qure.ai to implement a comprehensive AI suite for lung cancer care.
- The strategic collaboration is designed to prepare the health system for a province-wide screening program while simultaneously deploying AI to detect "incidental" lung nodules in routine X-rays and CT scans. By integrating tools for detection, quantification, and patient
Read More
Improving Pharmacy Workflows: PQS and Pyrls Launch “Zero-Click” Clinical Intelligence Tool
What You Should Know:
- Pharmacy Quality Solutions (PQS), an Innovaccer company, has partnered with Pyrls, a Y Combinator-backed drug information platform, to embed clinical data directly into the EQUIPP Copilot workflow.
- The integration allows pharmacists to access drug summaries, interaction screenings, and counseling points instantly without toggling between different systems. The collaboration aims to streamline clinical decision-making, reduce workflow friction, and
Read More
Noom Pivots to Longevity: New Program Combines Microdose GLP-1s with At-Home Biomarker Testing
What You Should Know:
- Noom has launched Proactive Health Microdose GLP-1Rx, a first-of-its-kind preventive health program designed to intervene before chronic disease takes root.
- Available to individuals with a BMI of 21 or higher, the offering combines personalized microdoses of GLP-1 medication with comprehensive at-home biomarker testing and Noom’s digital behavior modification platform.
- Priced at $149 per month, the program aims to shift the healthcare paradigm
Read More
PHTI Report 2025: 5 Strategies for Employers to Manage GLP-1 Costs and Coverage
What You Should Know:
- The Peterson Health Technology Institute (PHTI) has released a critical purchasing guide for employers struggling to manage the skyrocketing costs of GLP-1 obesity medications.
- The report recommends a shift away from broad, unchecked coverage toward a managed approach focused on three phases: Initiation (strict eligibility), Maintenance (adherence support), and Supported Discontinuation (managing off-ramps).
- PHTI urges employers to demand
Read More
